Vitamin C and Tyrosine Kinase Inhibitor in Lung Cancer Patients With Epidermal Growth Factor Receptor Mutations
Clinical trial NCT03799094 · UNKNOWN
Trial details
- NCT number
- NCT03799094
- Sponsor
- Clifford Hospital, Guangzhou, China
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-05
- Primary completion
- 2020-12-31
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.